These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7981009)
21. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline. Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322 [TBL] [Abstract][Full Text] [Related]
22. The effects of four beta-adrenoceptor antagonists during modest exercise on plasma ammonia and heart rate. Hall PE; Smith SR; Kendall MJ Clin Sci (Lond); 1987 Jun; 72(6):679-82. PubMed ID: 2885122 [TBL] [Abstract][Full Text] [Related]
23. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. Lipworth BJ; Clark DJ; Koch P; Arbeeny C Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370 [TBL] [Abstract][Full Text] [Related]
26. Oral β-blockade in relation to energy expenditure in clinically stable patients with liver cirrhosis: a double-blind randomized cross-over trial. Lee WG; McCall JL; Gane EJ; Murphy R; Plank LD Metabolism; 2012 Nov; 61(11):1547-53. PubMed ID: 22560128 [TBL] [Abstract][Full Text] [Related]
27. The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol. Lipworth BJ; Irvine NA; McDevitt DG Br J Clin Pharmacol; 1991 Feb; 31(2):154-9. PubMed ID: 1675576 [TBL] [Abstract][Full Text] [Related]
29. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Leenen FH; Davies RA; Fourney A Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044 [TBL] [Abstract][Full Text] [Related]
30. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. Tattersfield AE; Cragg DJ; Bacon RJ Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo. Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM Br J Clin Pharmacol; 1998 Mar; 45(3):271-6. PubMed ID: 9517371 [TBL] [Abstract][Full Text] [Related]
32. Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise. Peden NR; Dow RJ; Isles TE; Martin BT Br Med J (Clin Res Ed); 1984 Jun; 288(6433):1788-90. PubMed ID: 6145480 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic interaction of nadolol with itraconazole, rifampicin and grapefruit juice in healthy volunteers. Misaka S; Miyazaki N; Yatabe MS; Ono T; Shikama Y; Fukushima T; Kimura J J Clin Pharmacol; 2013 Jul; 53(7):738-45. PubMed ID: 23677858 [TBL] [Abstract][Full Text] [Related]
34. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias. Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720 [TBL] [Abstract][Full Text] [Related]
35. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug. Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988 [TBL] [Abstract][Full Text] [Related]
36. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise. Wilcox RG; Hampton JR Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268 [TBL] [Abstract][Full Text] [Related]
37. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Soszynski D; Kozak W; Conn CA; Rudolph K; Kluger MJ Neuroendocrinology; 1996 May; 63(5):459-67. PubMed ID: 8738584 [TBL] [Abstract][Full Text] [Related]
38. The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β Azadan RJ; Agha NH; Kunz HE; Baker FL; Mylabathula PL; Ledoux TA; O'Connor DP; Pedlar CR; Simpson RJ Eur J Appl Physiol; 2021 May; 121(5):1499-1511. PubMed ID: 33646423 [TBL] [Abstract][Full Text] [Related]
39. Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia. Leren IS; Saberniak J; Majid E; Haland TF; Edvardsen T; Haugaa KH Heart Rhythm; 2016 Feb; 13(2):433-40. PubMed ID: 26432584 [TBL] [Abstract][Full Text] [Related]
40. The effects of chronic dosing on the beta 1 and beta 2-adrenoceptor antagonism of betaxolol and atenolol. Lipworth BJ; Irvine NA; McDevitt DG Eur J Clin Pharmacol; 1991; 40(5):467-71. PubMed ID: 1653143 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]